DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



More Future Of...

What will MR look like in ten years? Insights from Michael Friebe, research professor of image-guided therapies at the Otto von Guericke University in Magdeburg Germany

The future of equipment upgrades Satrajit Misra, vice president of Marketing and Strategic Development, Canon Medical Systems Inc., on what lengthening replacement cycles mean for providers

The future of precision medicine Insights from Robert A. Cascella leader of Philips’ Diagnosis & Treatment businesses

The future of infusion systems: simplicity, interoperability, and security Insights from George Gray, CTO and VP of research and development for Ivenix

The future of portability in imaging Insights from Jim Burns, Carestream's senior director of R&D for imaging systems

See All Future Of...  

Molecular Imaging Homepage

New PET imaging method may yield benefits over FDG for detecting certain cancers Gallium-68-labeled FAPI tracer yields promising results

Dr. David Wong Professor recognized for contributions to PET and Theranostics

SVSR unveils Siemens Horizon PET/CT trailer Putting a small and powerful scanner on a coach

Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region

Under AMG, Piramal Imaging changes name to Life Molecular Imaging LMI is being run within the Alliance Medical Molecular Imaging division

RadioMedix Inc. and Curium to develop and commercialize PET agent 64Cu-Dotatate for use in suspected neuroendocrine tumors

Dr. Sanjiv Gambhir Stanford’s chair of radiology wins Cassen Prize

Researchers undertake 'largest brain study' using 60,000 SPECT images Evaluate accelerated brain aging in scans

SNMMI proposes solutions to Ga-68 generator shortage Combating waiting periods of between 14 and 18 months

Tc-99m generator production resumes in Australia Follows month and a half shutdown due to conveyor belt issue

Mike Barber

The future of molecular imaging

By Mike Barber
From the June 2018 issue of DOTmed HealthCare Business News magazine

Imagine a world where the 12.7 million people who face a cancer diagnosis every year do not have to wait six months for a personalized treatment recommendation, and then another year to see if that treatment is effective.

Where a doctor – over the course of one day – can use AI to combine a patient’s in vitro molecular disease profile (data from DNA sequencing and molecular pathology) with in vivo insights (molecular imaging) to proactively address cancer before it spreads. A change like this would turn medical care on its head.
Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

This is the future of precision health. And it will be enabled by the next wave of molecular imaging.

Since its inception in the early 1990s, molecular imaging has been the driving force behind personalized medicine, providing doctors with a detailed look inside patients’ bodies at the cellular level, so they can better understand each patient’s unique disease processes. While remarkable advances in imaging technology, tracers, quantitation, and post processing have been made in the past three decades, molecular imaging is at an inflection point. In the years ahead, patients’ diagnostic and treatment experiences will be significantly more precise and personalized, thanks to integrated, quantified data analyzed by AI plus new tracers.

Take, for example, a patient with prostate cancer. Today, that patient would see his oncologist to have his tumor biopsied. That biopsy would be sent to a separate team that would perform a histopathological evaluation of the tumor and run targeted proteomic and gene panels to determine the tumor’s molecular composition and pinpoint its mutational profile. That data would then be sent back to the oncologist, who would integrate this information, compare it to similar cases and use that data to recommend a treatment strategy.

If this same patient goes in for treatment in the future, his experience could be significantly more efficient, as digital tools could combine in vivo and in vitro diagnostics in one setting and help prevent unnecessary biopsies. If disease is detected, a more reliable image-guided biopsy would be performed on the most relevant region of the tumor for precise evaluation. The oncologist would receive a complete, quantified look at the patient’s profile enabling her to select the most effective therapeutic strategy and predict the patient’s response.

Theranostics, the idea of using the same delivery agent for targeted diagnostics and therapy, could be used to not only pinpoint the stage of a patient’s disease and predict how it will progress, but also to deliver precise therapy to the molecular and cellular disease targets. When therapy is delivered, diseased cells will be destroyed while healthy cells will be mostly unharmed, minimizing side effects.
  Pages: 1 - 2 >>

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.